News
AI Summary
20 Nov 202611 Jumada II 1448 AH
BioMap Launches AI System for Nonclinical Drug Safety Assessment

BioMap Launches AI System for Nonclinical Drug Safety Assessment

BioMap launched an AI-assisted drug safety assessment system on November 19, integrating virtual-cell models and toxicity prediction. This system is designed to help researchers prioritize candidate molecules and safety questions before committing to animal studies. A core component is the xTrimoTox model, built on a cell-world framework. The company is also exploring virtual dosing through safety-prediction models referred to as “virtual monkeys,” extending predictions to animal-level effects, which still require experimental validation.

Follow these topics

Sign in to follow the topics that matter to you

Sign in to follow

This summary is generated with AI and receives periodic editorial review. Refer to the original source for full details.

0
0 reading now

Insight Score

Rate to unlock

Sign in to react, rate, and save. Sign In

Key terms in this story

The top AI news daily on Telegram, and the week in your inbox.